Nordic Nanovector increases IPO deal size on high demand
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
EquityEquity IPOs

Nordic Nanovector increases IPO deal size on high demand

Pharmaceutical 230x150

Nordic Nanovector, the Norwegian biotech company, has increased the size of its initial public offering in Oslo to reflect strong investor demand for the deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article